Collaboration Program Plaque Analysis Sample Clauses

Collaboration Program Plaque Analysis. Merck, itself or through its Affiliates, shall be responsible for analyzing Biological Samples and Data in an effort to establish plaque biomarkers of atherosclerotic disease activity. Merck’s Collaboration Program plaque analysis responsibilities, include, but are not limited to, histology, all forms of protein and gene expression analysis, and all forms of lipid content analysis.